Korro Bio, Inc. (KRRO)

Korro Bio Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021
Cash & Equivalents	63.21	166.15	36.33	83.49
Short-Term Investments	73.79	-	18.92	35.04
Cash & Short-Term Investments	137	166.15	55.25	118.53
Cash Growth	197.05%	200.73%	-53.39%	-
Prepaid Expenses	3.42	3.02	1.23	0.64
Restricted Cash	1.77	3.56	0.6	0.6
Total Current Assets	152.78	172.73	57.08	119.78
Property, Plant & Equipment	53.13	42.82	11.89	6.45
Other Long-Term Assets	5.52	6.12	4.77	1.35
Total Assets	243.54	221.66	73.74	127.58
Accounts Payable	5.95	7.28	2.61	0.79
Accrued Expenses	4.9	9.82	3.18	3.22
Current Portion of Leases	-	1.99	2.92	-
Other Current Liabilities	0.56	0.4	-	0.94
Total Current Liabilities	13.61	19.48	8.7	4.95
Long-Term Leases	41.79	31.22	0.21	-
Other Long-Term Liabilities	0.72	1.05	-	0.97
Total Liabilities	63.91	51.75	8.91	5.92
Common Stock	0.01	0.01	-	0.01
Additional Paid-In Capital	424.44	352.91	2.81	1.6
Retained Earnings	-245.39	-183.01	-101.83	-43.8
Comprehensive Income & Other	0.57	-	-0.01	-0.01
Total Common Equity	179.63	169.91	-99.03	-42.21
Shareholders' Equity	179.63	169.91	64.83	121.66
Total Liabilities & Equity	243.54	221.66	73.74	127.58
Total Debt	41.79	33.21	3.13	-
Net Cash (Debt)	127.33	132.94	52.12	118.53
Net Cash Growth	754.60%	155.08%	-56.03%	-
Net Cash Per Share	16.12	86.93	204.24	26.65
Filing Date Shares Outstanding	9.37	8.02	5.65	4.45
Total Common Shares Outstanding	9.32	8.02	5.4	4.45
Working Capital	139.17	153.25	48.38	114.83
Book Value Per Share	19.28	21.20	-18.33	-9.49
Tangible Book Value	179.63	169.91	-99.03	-42.21
Tangible Book Value Per Share	19.28	21.20	-18.33	-9.49
Machinery	13	11.91	9.13	4.68
Construction In Progress	0.22	8.24	2.05	0.63
Leasehold Improvements	25.77	3.36	2.94	2.88

Source: S&P Capital IQ. Standard template. Financial Sources.